| COVID-19 |
1 |
1 |
| Mental Illness |
0 |
0.99 |
| Mood Disorders |
0 |
0.37 |
| Hospital |
0 |
0.3 |
| Intensive Care Unit |
0 |
0.3 |
| Anxiety Disorder |
0 |
0.27 |
| Psychiatric Hospital |
0 |
0.8 |
| Antipsychotics |
0 |
0.22 |
| Anxiolytic |
0 |
0.22 |
| Europe |
0 |
0.22 |
| Severe Acute Respiratory Syndrome (SARS) |
0 |
0.75 |
| Hypertension |
0 |
0.18 |
| Acute Respiratory Distress Syndrome |
0 |
0.17 |
| Vaccines |
0 |
0.17 |
| Antidepressant drug |
0 |
0.15 |
| Concerns of Elderly |
0 |
0.15 |
| Geriatrics |
0 |
0.15 |
| Health Care Quality, Access, and Evaluation |
0 |
0.8 |
| Immunization |
0 |
0.15 |
| Tobacco Use |
0 |
0.13 |
| Depression |
0 |
0.45 |
| Social Determinants of Health |
0 |
0.4 |
| Arrhythmia |
0 |
0.1 |
| Cardiovascular Risk Management |
0 |
0.1 |
| Intellectual Disability |
0 |
0.1 |
| Tobacco Cessation |
0 |
0.1 |
| Anxiety |
0 |
0.07 |
| Benzodiazepines |
0 |
0.07 |
| Cancer |
0 |
0.07 |
| Cardiovascular disease |
0 |
0.07 |
| Cytokines |
0 |
0.07 |
| Diet |
0 |
0.07 |
| Disability |
0 |
0.07 |
| Grant |
0 |
0.07 |
| Heart |
0 |
0.07 |
| Isolation |
0 |
0.3 |
| Meta-Analysis |
0 |
0.07 |
| Mild Hypertension |
0 |
0.07 |
| New York |
0 |
0.07 |
| Pandemic |
0 |
0.3 |
| Referral |
0 |
0.07 |
| Sleep |
0 |
0.07 |
| Stress |
0 |
0.07 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.06 |
| Obesity |
0 |
0.06 |
| Sleep Disorders |
0 |
0.06 |